Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 55

1.

aSIRTing control over cancer stem cells.

Ito T, Zimdahl B, Reya T.

Cancer Cell. 2012 Feb 14;21(2):140-2. doi: 10.1016/j.ccr.2012.01.014.

PMID:
22340585
[PubMed]
Free Article
2.

The Alox5 gene is a novel therapeutic target in cancer stem cells of chronic myeloid leukemia.

Chen Y, Li D, Li S.

Cell Cycle. 2009 Nov 1;8(21):3488-92. Epub 2009 Nov 19.

PMID:
19823023
[PubMed - indexed for MEDLINE]
Free Article
3.

Novel therapeutic approach to eradicate tyrosine kinase inhibitor resistant chronic myeloid leukemia stem cells.

Naka K, Hoshii T, Hirao A.

Cancer Sci. 2010 Jul;101(7):1577-81. doi: 10.1111/j.1349-7006.2010.01584.x. Epub 2010 Apr 5. Review.

PMID:
20491777
[PubMed - indexed for MEDLINE]
4.

The chronic myeloid leukemia stem cell.

Nicholson E, Holyoake T.

Clin Lymphoma Myeloma. 2009;9 Suppl 4:S376-81. doi: 10.3816/CLM.2009.s.037. Review.

PMID:
20007106
[PubMed - indexed for MEDLINE]
5.

Differences in the frequency of normal and clonal precursors of colony-forming cells in chronic myelogenous leukemia and acute myelogenous leukemia.

Bernstein ID, Singer JW, Smith FO, Andrews RG, Flowers DA, Petersens J, Steinmann L, Najfeld V, Savage D, Fruchtman S, et al.

Blood. 1992 Apr 1;79(7):1811-6.

PMID:
1373089
[PubMed - indexed for MEDLINE]
Free Article
6.

Instability of BCR-ABL gene in primary and cultured chronic myeloid leukemia stem cells.

Jiang X, Saw KM, Eaves A, Eaves C.

J Natl Cancer Inst. 2007 May 2;99(9):680-93.

PMID:
17470736
[PubMed - indexed for MEDLINE]
Free Article
7.

The challenges of targeting chronic myeloid leukemia stem cells.

Jiang X, Smith C, Eaves A, Eaves C.

Clin Lymphoma Myeloma. 2007 Mar;7 Suppl 2:S71-80. Review.

PMID:
17382016
[PubMed - indexed for MEDLINE]
8.

Inhibition of autophagy: a new strategy to enhance sensitivity of chronic myeloid leukemia stem cells to tyrosine kinase inhibitors.

Calabretta B, Salomoni P.

Leuk Lymphoma. 2011 Feb;52 Suppl 1:54-9. doi: 10.3109/10428194.2010.546913. Epub 2011 Jan 21. Review.

PMID:
21250825
[PubMed - indexed for MEDLINE]
9.

Loss of the Alox5 gene impairs leukemia stem cells and prevents chronic myeloid leukemia.

Chen Y, Hu Y, Zhang H, Peng C, Li S.

Nat Genet. 2009 Jul;41(7):783-92. doi: 10.1038/ng.389. Epub 2009 Jun 7.

PMID:
19503090
[PubMed - indexed for MEDLINE]
Free PMC Article
10.

Results with high-dose chemotherapy and unpurged autologous stem cell transplantation in 73 patients with chronic myelogenous leukemia: the MD Anderson experience.

Khouri IF, Kantarjian HM, Talpaz M, Giralt S, Rios MO, Hester JP, Champlin RE, Deisseroth AB.

Bone Marrow Transplant. 1996 May;17(5):775-9.

PMID:
8733697
[PubMed - indexed for MEDLINE]
11.

Why do chronic myelogenous leukemia stem cells survive allogeneic stem cell transplantation or imatinib: does it really matter?

Goldman J, Gordon M.

Leuk Lymphoma. 2006 Jan;47(1):1-7. Review.

PMID:
16321820
[PubMed - indexed for MEDLINE]
12.

T cells recognizing leukemic CD34(+) progenitor cells mediate the antileukemic effect of donor lymphocyte infusions for relapsed chronic myeloid leukemia after allogeneic stem cell transplantation.

Smit WM, Rijnbeek M, van Bergen CA, Fibbe WE, Willemze R, Falkenburg JH.

Proc Natl Acad Sci U S A. 1998 Aug 18;95(17):10152-7.

PMID:
9707616
[PubMed - indexed for MEDLINE]
Free PMC Article
13.

Knocking the Wnt out of the sails of leukemia stem cell development.

Deshpande AJ, Buske C.

Cell Stem Cell. 2007 Dec 13;1(6):597-8. doi: 10.1016/j.stem.2007.11.006. Review.

PMID:
18371398
[PubMed - indexed for MEDLINE]
Free Article
14.

Chronic myelogenous leukemia: molecular and cellular aspects.

Pasternak G, Hochhaus A, Schultheis B, Hehlmann R.

J Cancer Res Clin Oncol. 1998;124(12):643-60. Review.

PMID:
9879825
[PubMed - indexed for MEDLINE]
15.

Chronic myeloid leukemia stem cells.

Jamieson CH.

Hematology Am Soc Hematol Educ Program. 2008:436-42. doi: 10.1182/asheducation-2008.1.436. Review.

PMID:
19074122
[PubMed - indexed for MEDLINE]
Free Article
16.

Chronic myeloid leukemia in 2007.

Sessions J.

J Manag Care Pharm. 2007 Oct;13(8 Suppl A):4-7. Review.

PMID:
17970608
[PubMed - indexed for MEDLINE]
Free Article
18.

Tumour antigen-targeted immunotherapy for chronic myeloid leukaemia: is it still viable?

Riley CL, Mathieu MG, Clark RE, McArdle SE, Rees RC.

Cancer Immunol Immunother. 2009 Sep;58(9):1489-99. doi: 10.1007/s00262-009-0675-x. Epub 2009 Mar 4. Review.

PMID:
19259670
[PubMed - indexed for MEDLINE]
19.

Targeted chemotherapy: chronic myelogenous leukemia as a model.

Sharifi N, Steinman RA.

J Mol Med (Berl). 2002 Apr;80(4):219-32. Epub 2002 Jan 24. Review.

PMID:
11976731
[PubMed - indexed for MEDLINE]
20.

Molecular pathways to CML stem cells.

Rice KN, Jamieson CH.

Int J Hematol. 2010 Jun;91(5):748-52. doi: 10.1007/s12185-010-0615-8. Epub 2010 Jun 10. Review.

PMID:
20533007
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk